231 related articles for article (PubMed ID: 9016896)
1. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients.
Peces R; de la Torre M; Alcázar R; Urra JM
Am J Kidney Dis; 1997 Feb; 29(2):239-45. PubMed ID: 9016896
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two immunization schedules with recombinant hepatitis B vaccine and natural immunity acquired by hepatitis B infection in dialysis patients.
el-Reshaid K; al-Mufti S; Johny KV; Sugathan TN
Vaccine; 1994; 12(3):223-34. PubMed ID: 8165854
[TBL] [Abstract][Full Text] [Related]
3. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
[TBL] [Abstract][Full Text] [Related]
4. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
[TBL] [Abstract][Full Text] [Related]
5. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
Kayataş M
Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
7. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
[TBL] [Abstract][Full Text] [Related]
8. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis].
Pin M; Compte MT; Angelet P; Gállego C; Gutiérrez C; Martinez Vea A
Nefrologia; 2009; 29(5):415-20. PubMed ID: 19820753
[TBL] [Abstract][Full Text] [Related]
9. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response.
Peces R; Laurés AS
Nephron; 2001 Oct; 89(2):172-6. PubMed ID: 11549899
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
11. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients?
Jadoul M; Goubau P
Clin Nephrol; 2002 Oct; 58(4):301-4. PubMed ID: 12400846
[TBL] [Abstract][Full Text] [Related]
12. Antibody level after hepatitis-B vaccination in hemodialysis patients: impact of dialysis adequacy, chronic inflammation, local endemicity and nutritional status.
Ibrahim S; el-Din S; Bazzal I
J Natl Med Assoc; 2006 Dec; 98(12):1953-7. PubMed ID: 17225840
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection.
Cheng CH; Huang CC; Leu ML; Chiang CY; Wu MS; Lai PC
Vaccine; 1997; 15(12-13):1353-7. PubMed ID: 9302744
[TBL] [Abstract][Full Text] [Related]
14. Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients.
Lin SY; Liu JH; Lin CC; Wang SM; Tsai CA; Chou CY; Kuo HL; Wang IK; Liu YL; Lin HH; Huang CC
Vaccine; 2011 May; 29(21):3738-41. PubMed ID: 21458609
[TBL] [Abstract][Full Text] [Related]
15. Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population.
Charest AF; Grand'Maison A; McDougall J; Goldstein MB
Am J Kidney Dis; 2003 Dec; 42(6):1193-9. PubMed ID: 14655191
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
[TBL] [Abstract][Full Text] [Related]
17. Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.
Wiedmann M; Liebert UG; Oesen U; Porst H; Wiese M; Schroeder S; Halm U; Mössner J; Berr F
Hepatology; 2000 Jan; 31(1):230-4. PubMed ID: 10613751
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
[TBL] [Abstract][Full Text] [Related]
19. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting response to hepatitis B vaccine among hemodialysis patients in a large Saudi Hemodialysis Center.
Al Saran K; Sabry A; Al Halawany Z; Ismail M
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):185-91. PubMed ID: 24434410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
